1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter's Fiver Forces Analysis 35
3 Segmentation of Asia Pacific Market by Source 39
3.1 Market Overview by Source 39
3.2 Synthetic API 41
3.2.1 Branded Synthetic API 42
3.2.2 Generic Synthetic API 43
3.3 Semi-synthetic API 44
3.4 Natural Origin 45
4 Segmentation of Asia Pacific Market by Type 46
4.1 Market Overview by Type 46
4.2 Standard API 48
4.3 High Potency API (HPAPI) 49
4.3.1 Branded HPAPI 50
4.3.2 Generic HPAPI 51
5 Segmentation of Asia Pacific Market by Therapeutic Area 52
5.1 Market Overview by Therapeutic Area 52
5.2 Infectious Diseases 54
5.3 Oncology 55
5.4 Ophthalmology 56
5.5 Cardiovascular Disorders 57
5.6 Central Nervous System 58
5.7 Respiratory Disorders 59
5.8 Metabolic Diseases 60
5.9 Other Applications 61
6 Segmentation of Asia Pacific Market by Application 62
6.1 Market Overview by Application 62
6.2 Clinical Use 64
6.3 Commercial Use 65
7 Segmentation of Asia Pacific Market by Manufacturer Type 66
7.1 Market Overview by Manufacturer Type 66
7.2 Pharmaceutical Companies 68
7.3 CMOs 70
8 Asia-Pacific Market 2020-2027 by Country 72
8.1 Overview of Asia-Pacific Market 72
8.2 China 75
8.3 Japan 77
8.4 India 80
8.5 Australia 82
8.6 South Korea 84
8.7 Rest of APAC Region 86
9 Competitive Landscape 88
9.1 Overview of Key Vendors 88
9.2 New Product Launch, Partnership, Investment, and M&A 91
9.3 Company Profiles 92
Aurobindo Pharma Ltd. 92
Cambrex Corporation 94
Catalent, Inc. 95
Dr. Reddy's Laboratories Ltd. 96
GlaxoSmithKline plc 97
Lonza Group 98
Merck & Co., Inc. 99
Mylan N.V. 100
Novartis AG 101
Pfizer Inc. 102
Sun Pharmaceutical Industries Ltd. 103
Teva Pharmaceutical Industries Ltd. 104
Wuxi AppTec Co., Ltd. 105
10 Investing in Asia Pacific Market: Risk Assessment and Management 106
10.1 Risk Evaluation of Asia Pacific Market 106
10.2 Critical Success Factors (CSFs) 109
Related Reports and Products 112